ORIC PHARMACEUTICALS INC

Oric (ORIC) rises 0.51% as investors eye its oncology pipeline—solid 200‑day SMA, 52‑week high near reach, and a 1.4 B market cap.

Oric (ORIC) surges 8.33% to $13.85, topping a $1.3B market cap. Learn why the cancer‑therapy firm is outperforming peers and what’s driving this momentum.